#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-neutrophil cytoplasmic antibody positive vasculitis Chronic lymphocytic leukaemia refractory Orthostatic hypotension Ewing's sarcoma Peritoneal neoplasm Optic ischaemic neuropathy Heart disease congenital Niemann-Pick disease Congenital aplastic anaemia Neuroendocrine carcinoma of the skin Li-Fraumeni syndrome Netherton's syndrome Neuroendocrine tumour Liposarcoma metastatic Enteritis More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Life with Disease MELAS syndrome – Diagnostics Andersen-Tawil syndrome – Treatment Hereditary hypophosphataemic rickets – Treatment Haemophilia – Treatment Breast angiosarcoma metastatic – Trials in Disease IgA nephropathy – Diagnostics Lymphatic malformation – Diagnostics Hereditary motor and sensory neuropathy – Basic Information Glycogen storage disease type V – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Artemisia Vulgaris Dapagliflozin Rugonersen Vindesine Sulfate Rezafungin Acetate Escitalopram Oxalate Magnesium Citrate Immunglobulin NVG-2089 Dextromethadone Hydrochloride Inupadenant Hydrochloride Amitriptyline Hydrochloride Bezafibrate Norfloxacin Tasimelteon Hydralazine Hydrochloride Cocarboxylase Tetrahydrate Pegcetacoplan Ceftriaxone Sodium Fenfluramine Hydrochloride More therapies…

    Learn about Your Condition

    Pyelonephritis Chondrosarcoma Renal disorder Breast cancer Anal cancer metastatic Neonatal anoxia Undifferentiated sarcoma Asymptomatic HIV infection Angelman's syndrome Malabsorption Actinic cheilitis Breast cancer stage IV Paedophilia Naevoid melanoma Cartilage injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study of LY3871801 for Adults with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Ly3871801
    Czechia France Germany Hungary Poland Slovakia

  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Bulgaria Czechia Denmark France Portugal Slovakia

  • Study Comparing Setrusumab and Bisphosphonates for Children with Osteogenesis Imperfecta

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • Neridronate Sodium
    • Pamidronate Disodium
    • Setrusumab
    France Germany Italy The Netherlands Poland

  • Clonidine Hydrochloride for Pain Management After Spine Surgery in Patients with Degenerative Spine Diseases

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Clonidine Hydrochloride
    • Sodium Chloride
    Denmark

  • Study on the Safety and Effects of SYN321 Injections for Patients with Knee Osteoarthritis

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Syn321
    • Sodium Chloride
    Sweden

  • Study of intravenous immunoglobulin combined with prednisone compared to prednisone alone in newly diagnosed patients with inflammatory myositis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    The Netherlands
Previous Page
1 … 64 65 66 67 68
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!